Company: TVRD
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0001104659-25-030583
Chunk: 1

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-04-01
Form: 8-K
Item: Item 8.01
Chunk 1
---
Item 8.01      Other Events.  

The Company is filing this Current Report on Form
8-K to provide certain financial information with respect to the Merger. Specifically, this Current Report on Form 8-K provides: (i) audited
financial statements of Tvardi as of and for the years ended December 31, 2024 and 2023, attached hereto as Exhibit 99.1 and incorporated
herein by reference, (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations of Tvardi for the
years ended December 31, 2024 and 2023, attached hereto as Exhibit 99.2 and incorporated herein by reference, and (iii) the unaudited
pro forma condensed combined financial statements as of and for the year ended December 31, 2024, relating to the proposed Merger, attached
hereto as Exhibit 99.3 and incorporated herein by reference. Such unaudited pro forma condensed combined financial statements have been
prepared on the basis of certain assumptions and estimates and are subject to other uncertainties and do not purport to reflect what the
actual results of operations or financial condition of the combined company would have been had the Merger been consummated on the dates
assumed for purposes of such pro forma financial statements or to be indicative of the financial condition or results of operations of
the combined company as of or for any future date or period. For further information, see Exhibit 99.3. The information in Exhibits 99.1
and 99.2 were provided by Tvardi.